Chandler Robinson - Chief Executive Officer, Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

Chandler Robinson - trading volume in the past year for Monopar Therapeutics

Holdings reported by Chandler Robinson for Monopar Therapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 85,718 $5,596,768 $65.29 28 Jan 2025 Direct
Common Stock 62,815 $4,101,367 $65.29 28 Jan 2025 Indirect
Restricted Stock Units 121,732 $3,446,898 $36.41 02 Dec 2025 Direct Common Stock
Restricted Stock Unit 113,008 31 Dec 2025 Direct Common Stock
Stock Options 16,753 02 Dec 2025 Direct Common Stock

Transactions reported by Chandler Robinson for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.